MyAverix Finance
NS · Pharmaceuticals
Albert David Ltd (ALBERTDAVD)
Pharmaceuticals & Biotechnology
Albert David Ltd (ALBERTDAVD) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $4.10B, P/E ratio is -272.56, net margin is 7.4%, dividend yield is 0.70%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for ALBERTDAVD
Albert David Ltd (ALBERTDAVD) — FAQ
What is Albert David Ltd's market cap?
Albert David Ltd (ALBERTDAVD) has a reported market cap of $4.10B (data as of 2026-07-10).
What is ALBERTDAVD's P/E ratio?
The price-to-earnings (P/E) ratio for Albert David Ltd (ALBERTDAVD) is -272.56 (data as of 2026-07-10).
Does Albert David Ltd pay a dividend?
Albert David Ltd (ALBERTDAVD) shows a reported dividend yield of 0.70%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Albert David Ltd in?
Albert David Ltd (ALBERTDAVD) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is ALBERTDAVD listed on?
ALBERTDAVD is listed on NS.
What is Albert David Ltd's net margin?
Albert David Ltd (ALBERTDAVD) reports a net margin of 7.4% (data as of 2026-07-10).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.